Aims and Scope of Expert Review of Hematology
Expert Review of Hematology is a MEDLINE-indexed, peer-reviewed, international medical journal publishing review articles and original papers on all aspects of hematology. It is part of the Expert Review series, published by Informa. Less
Key Metrics
CiteScore 

4.2
H-Index 

49
Impact Factor 

< 5
SJR 

Q2Hematology

SNIP 

0.99
Recommended pre-submission checks
Powered by 

Topics Covered on Expert Review of Hematology
Expert Review of Hematology Journal Specifications
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2008 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Expert Review of Hematology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Expert Review of Hematology
Efficacy of pacritinib versus momelotinib in patients with thrombocytopenic myelofibrosis: a matching-adjusted indirect treatment comparison
- 2 Sep 2026
- Expert Review of Hematology
ADAMTS13 activity and clinical outcomes: a targeted literature review in congenital thrombotic thrombocytopenic purpura and other related thrombotic conditions
- 3 Jul 2026
- Expert Review of Hematology
The impact of a cancer diagnosis for myeloproliferative neoplasm (MPN) patients.
- 29 Jun 2026
- Expert review of hematology
Lessons from warfarin management during the COVID-19 pandemic: from crisis to an opportunity to revolutionize telemedicine for chronic disease care
- 27 Jun 2026
- Expert Review of Hematology
Prognostic factors for patients with relapsed or refractory multiple myeloma who are initiating a fourth or later line car T-cell or bispecific antibody therapy: a systematic literature review and meta-analysis
- 24 Jun 2026
- Expert Review of Hematology
Polycythemia vera and metabolic syndrome: is the relationship between the two diseases more than we think?
- 21 Jun 2026
- Expert Review of Hematology
Efficacy of pacritinib versus momelotinib in patients with thrombocytopenic myelofibrosis: a matching-adjusted indirect treatment comparison
- 2 Sep 2026
- Expert Review of Hematology
ADAMTS13 activity and clinical outcomes: a targeted literature review in congenital thrombotic thrombocytopenic purpura and other related thrombotic conditions
- 3 Jul 2026
- Expert Review of Hematology
The impact of a cancer diagnosis for myeloproliferative neoplasm (MPN) patients.
- 29 Jun 2026
- Expert review of hematology
Lessons from warfarin management during the COVID-19 pandemic: from crisis to an opportunity to revolutionize telemedicine for chronic disease care
- 27 Jun 2026
- Expert Review of Hematology
Prognostic factors for patients with relapsed or refractory multiple myeloma who are initiating a fourth or later line car T-cell or bispecific antibody therapy: a systematic literature review and meta-analysis
- 24 Jun 2026
- Expert Review of Hematology
Polycythemia vera and metabolic syndrome: is the relationship between the two diseases more than we think?
- 21 Jun 2026
- Expert Review of Hematology